{"id":79315,"date":"2022-01-25T15:02:40","date_gmt":"2022-01-25T14:02:40","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?post_type=ecosystem&p=79315"},"modified":"2022-01-25T15:02:42","modified_gmt":"2022-01-25T14:02:42","slug":"inveox","status":"publish","type":"ecosystem","link":"https:\/\/cms.munich-startup.net\/en\/startups\/inveox\/","title":{"rendered":"inveox GmbH"},"content":{"rendered":"

Pathology 4.0\u00ae \u2013 the laboratory of the future<\/p>\n

Founded in Munich in 2017, inveox GmbH develops systems for digitizing and automating sample receipt in histopathology and for networking pathology laboratories and treating physicians.<\/p>\n

Time-consuming, highly manual laboratory processes in pathology are expensive, error-prone, and the most common cause of misdiagnoses. inveox has developed an innovative solution for the capture, receipt, and preparation of histopathological laboratory samples. The system consists of an intelligent sample container, an automated sample receipt machine, and an online platform for data transfer between the treating physician and the laboratory. With digitized, fully automated, and networked histopathology, inveox aims to improve the safety and reliability of cancer diagnoses while increasing laboratory efficiency and profitability and unlocking the potential for personalized diagnostics based on big data and artificial intelligence.<\/p>\n

Since its founding, inveox has won numerous awards and was a finalist in the Digital Start-up of the Year 2020 award from the Federal Ministry for Economic Affairs and Energy, the EIT Health Award 2019, the German Innovation Award 2019 and the World Health Summit Award 2018. The young company made it onto the Forbes list of "Most Promising Startups 2018", has been a member of the World Economic Forum since 2019 and has already been featured in articles and reports in various renowned print media such as Handelsblatt and Wirtschaftswoche.<\/p>\n

With offices in Krakow (Poland) and Houston (Texas, USA), the startup now has over 100 team members.<\/p>\n<\/div>","protected":false},"featured_media":55838,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"ecosystem_type":[2],"ecosystem_tag":[2793,2759,2748,2742,2707],"acf":[],"yoast_head":"\ninveox GmbH - Munich Startup<\/title>\n<meta name=\"description\" content=\"inveox entwickelt Systeme zur Digitalisierung und Automatisierung des Probeneingangs in der Histopathologie sowie zur Vernetzung von Pathologielaboren und behandelnden \u00c4rzten.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/startups\/inveox\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"inveox GmbH - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"inveox entwickelt Systeme zur Digitalisierung und Automatisierung des Probeneingangs in der Histopathologie sowie zur Vernetzung von Pathologielaboren und behandelnden \u00c4rzten.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/startups\/inveox\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-25T14:02:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/\",\"url\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/\",\"name\":\"inveox GmbH - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg\",\"datePublished\":\"2022-01-25T14:02:40+00:00\",\"dateModified\":\"2022-01-25T14:02:42+00:00\",\"description\":\"inveox entwickelt Systeme zur Digitalisierung und Automatisierung des Probeneingangs in der Histopathologie sowie zur Vernetzung von Pathologielaboren und behandelnden \u00c4rzten.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/startups\/inveox\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg\",\"width\":1200,\"height\":596,\"caption\":\"inveox GmbH\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/inveox\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"inveox GmbH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"596\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"inveox GmbH - Munich Startup","description":"inveox develops systems for digitizing and automating sample receipt in histopathology and for networking pathology laboratories and treating physicians.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/startups\/inveox\/","og_locale":"en_US","og_type":"article","og_title":"inveox GmbH - Munich Startup","og_description":"inveox entwickelt Systeme zur Digitalisierung und Automatisierung des Probeneingangs in der Histopathologie sowie zur Vernetzung von Pathologielaboren und behandelnden \u00c4rzten.","og_url":"https:\/\/cms.munich-startup.net\/en\/startups\/inveox\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_modified_time":"2022-01-25T14:02:42+00:00","twitter_card":"summary_large_image","twitter_site":"@munich_startup","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/startups\/inveox\/","url":"https:\/\/cms.munich-startup.net\/startups\/inveox\/","name":"inveox GmbH - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/startups\/inveox\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/startups\/inveox\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg","datePublished":"2022-01-25T14:02:40+00:00","dateModified":"2022-01-25T14:02:42+00:00","description":"inveox develops systems for digitizing and automating sample receipt in histopathology and for networking pathology laboratories and treating physicians.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/startups\/inveox\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/startups\/inveox\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/startups\/inveox\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg","width":1200,"height":596,"caption":"inveox GmbH"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/startups\/inveox\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"inveox GmbH"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]},"og_image":[{"width":1200,"height":596,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/12\/inveox-GmbH.jpeg","type":"image\/jpeg"}]},"_location_name":"","_location_street":"Lichtenbergstra\u00dfe 8","_location_zip":"85478","_location_city":"Garching","_ecosystem_type":"startup","_foundingyear":"2017","_showyear":"1","_show_financing":"","_inactive":"","_founders":"2","_employees":"","_businessmodel":"B2B","_stage":"Startup-Stage","_financing":"","_investors":"","_investor_funding_rounds":"","_investor_details":"","_financing_history":"[{\"ecosystem_funding_round\":\"\",\"ecosystem_funding_year\":\"\",\"ecosystem_funding_amount\":\"\"}]","_apple_appstore":"","_google_play":"","_user_email":"maria.driesel@inveox.com","_user_password":"$2y$10$.xeE5OMLXJV9mZQwyOx9uuH74AqxmiLmqJPGgLjc8c8HAiRNdvGLq","_description_en":"Pathology 4.0\u00a9 - the lab of the future.\r\n\r\nFounded in Munich in 2017,\u00a0inveox\u00a0develops systems to digitize, automate and connect histopathology laboratories\u00a0and physicians. The\u00a0aim is to increase the safety and reliability of cancer diagnoses, while at the same time improving the efficiency and profitability of laboratories and tapping the potential for personalized diagnostics based on big data and AI.\u00a0\r\n\r\nHaving won\u00a0numerous\u00a0awards,\u00a0inveox\u00a0was\u00a0a\u00a0finalist for the 2020 Digital Startup of the Year Award\u00a0by\u00a0Germany\u2019s\u00a0Federal\u00a0Ministry\u00a0of Economics,\u00a0the\u00a02019 EIT Woman Award, and the 2018 World Health Summit Award.\u00a0Inveox\u00a0also\u00a0made it onto the\u00a02018\u00a0Forbes list of\u00a0\u201cmost promising startups\u201d and\u00a0has\u00a0been\u00a0covered by\u00a0large\u00a0media outlets such as\u00a0Handelsblatt\u00a0and\u00a0Wirtschaftswoche.\u00a0The\u00a0medtech\u00a0company\u00a0has also been a\u00a0member of the World Economic Forum\u00a0since 2019.\r\n\r\nWith\u00a0subsidiaries in\u00a0Krakow, Poland, and Houston, Texas, USA, the\u00a0young company\u00a0currently\u00a0comprises of\u00a0over 100\u00a0team members\u00a0in all offices.","_founders_description":"","_founders_image":"","_logo_image":"","_contact":{"tel":"089 57847601","hp":"http:\/\/www.inveox.com","mail":"marcom@inveox.com","facebook":"","twitter":"https:\/\/twitter.com\/inveox","instagram":"https:\/\/de.linkedin.com\/company\/inveox"},"_thumbnail_id":"55838","_edit_lock":"1643119518:25","_edit_last":"25","_location_lat":"48.2686617","_location_long":"11.6650793","_wp_old_slug":"inveox-2","wbounce_status":"default","_yoast_wpseo_primary_ecosystem_type":"2","_yoast_wpseo_primary_ecosystem_tag":"2742","_hide_on_map":"","_yoast_wpseo_content_score":"60","dealroom_id":"1513812","_dealroom_id":"field_5ea15c1318719","dealroom_json":"{\"id\":1513812,\"name\":\"Inveox\",\"url\":\"https:\/\/app.dealroom.co\/companies\/inveox\",\"total_funding\":23.05,\"employees_chart\":[{\"date\":\"2018-12-01\",\"value\":54},{\"date\":\"2018-12-31\",\"value\":54},{\"date\":\"2019-03-01\",\"value\":63},{\"date\":\"2019-06-01\",\"value\":74},{\"date\":\"2019-06-30\",\"value\":74},{\"date\":\"2019-09-01\",\"value\":81},{\"date\":\"2019-12-01\",\"value\":89},{\"date\":\"2019-12-31\",\"value\":89},{\"date\":\"2020-03-01\",\"value\":94},{\"date\":\"2020-06-01\",\"value\":99},{\"date\":\"2020-06-30\",\"value\":99},{\"date\":\"2020-07-31\",\"value\":99},{\"date\":\"2021-01-31\",\"value\":109},{\"date\":\"2021-07-31\",\"value\":107},{\"date\":\"2022-01-31\",\"value\":93},{\"date\":\"2022-07-06\",\"value\":49},{\"date\":\"2022-07-15\",\"value\":46},{\"date\":\"2022-07-22\",\"value\":44},{\"date\":\"2022-08-21\",\"value\":40},{\"date\":\"2022-09-20\",\"value\":38},{\"date\":\"2022-10-21\",\"value\":36},{\"date\":\"2022-11-21\",\"value\":35},{\"date\":\"2022-12-22\",\"value\":36},{\"date\":\"2023-01-22\",\"value\":33},{\"date\":\"2023-02-12\",\"value\":34},{\"date\":\"2023-03-14\",\"value\":33},{\"date\":\"2023-04-13\",\"value\":29},{\"date\":\"2023-05-13\",\"value\":31},{\"date\":\"2023-06-15\",\"value\":31},{\"date\":\"2023-07-17\",\"value\":31},{\"date\":\"2023-08-20\",\"value\":29},{\"date\":\"2023-09-19\",\"value\":28},{\"date\":\"2023-10-19\",\"value\":28},{\"date\":\"2023-11-18\",\"value\":30},{\"date\":\"2023-12-18\",\"value\":28},{\"date\":\"2024-01-17\",\"value\":28},{\"date\":\"2024-03-19\",\"value\":28}],\"employees_latest\":28,\"employee_12_months_growth_unique\":141623,\"employee_12_months_growth_percentile\":null,\"app_12_months_growth_percentile\":null,\"app_12_months_growth_unique\":null,\"app_12_months_growth_relative\":null,\"fundings\":{\"items\":[{\"id\":278159,\"year\":2019,\"month\":8,\"amount\":17,\"amount_source\":17000000,\"currency\":\"EUR\",\"round\":\"EARLY VC\",\"valuation\":null,\"valuation_generated_min\":68000000,\"valuation_generated_max\":102000000,\"news_source\":\"https:\/\/www.vc-magazin.de\/blog\/2019\/08\/05\/54295\/\",\"investors\":[],\"is_verified\":true,\"amount_eur_million\":17,\"amount_usd_million\":18.7},{\"id\":341322,\"year\":2018,\"month\":10,\"amount\":null,\"amount_source\":0,\"currency\":\"EUR\",\"round\":\"GRANT\",\"valuation\":null,\"valuation_generated_min\":null,\"valuation_generated_max\":null,\"news_source\":null,\"investors\":[{\"type\":\"fund\",\"id\":901563,\"name\":\"EIT Health\",\"path\":\"eit_health\",\"sub_types\":[\"accelerator\"],\"url\":\"https:\/\/app.dealroom.co\/investors\/eit_health\",\"images\":{\"32x32\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/c7\/MzI6MzI6Y29tcGFueUBzMy1ldS13ZXN0LTEuYW1hem9uYXdzLmNvbS9kZWFscm9vbS1pbWFnZXMvMjAyMi8wMy8wNy8wZDkzM2Q1YTY1ZGNmZDJiOWEzNTg0NjYxYzZiYWRmOQ==.jpeg\",\"74x74\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/82\/NzQ6NzQ6Y29tcGFueUBzMy1ldS13ZXN0LTEuYW1hem9uYXdzLmNvbS9kZWFscm9vbS1pbWFnZXMvMjAyMi8wMy8wNy8wZDkzM2Q1YTY1ZGNmZDJiOWEzNTg0NjYxYzZiYWRmOQ==.jpeg\",\"100x100\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/62\/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDIyLzAzLzA3LzBkOTMzZDVhNjVkY2ZkMmI5YTM1ODQ2NjFjNmJhZGY5.jpeg\"},\"lead\":false}],\"is_verified\":true,\"amount_eur_million\":null,\"amount_usd_million\":null},{\"id\":339009,\"year\":2018,\"month\":7,\"amount\":0.05,\"amount_source\":50000,\"currency\":\"EUR\",\"round\":\"GRANT\",\"valuation\":null,\"valuation_generated_min\":null,\"valuation_generated_max\":null,\"news_source\":null,\"investors\":[{\"type\":\"fund\",\"id\":901563,\"name\":\"EIT Health\",\"path\":\"eit_health\",\"sub_types\":[\"accelerator\"],\"url\":\"https:\/\/app.dealroom.co\/investors\/eit_health\",\"images\":{\"32x32\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/c7\/MzI6MzI6Y29tcGFueUBzMy1ldS13ZXN0LTEuYW1hem9uYXdzLmNvbS9kZWFscm9vbS1pbWFnZXMvMjAyMi8wMy8wNy8wZDkzM2Q1YTY1ZGNmZDJiOWEzNTg0NjYxYzZiYWRmOQ==.jpeg\",\"74x74\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/82\/NzQ6NzQ6Y29tcGFueUBzMy1ldS13ZXN0LTEuYW1hem9uYXdzLmNvbS9kZWFscm9vbS1pbWFnZXMvMjAyMi8wMy8wNy8wZDkzM2Q1YTY1ZGNmZDJiOWEzNTg0NjYxYzZiYWRmOQ==.jpeg\",\"100x100\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/62\/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDIyLzAzLzA3LzBkOTMzZDVhNjVkY2ZkMmI5YTM1ODQ2NjFjNmJhZGY5.jpeg\"},\"lead\":false}],\"is_verified\":true,\"amount_eur_million\":0.05,\"amount_usd_million\":0.06},{\"id\":278161,\"year\":2018,\"month\":1,\"amount\":5,\"amount_source\":5000000,\"currency\":\"EUR\",\"round\":\"EARLY VC\",\"valuation\":null,\"valuation_generated_min\":20000000,\"valuation_generated_max\":30000000,\"news_source\":null,\"investors\":[],\"is_verified\":true,\"amount_eur_million\":5,\"amount_usd_million\":5.5},{\"id\":786795,\"year\":2017,\"month\":2,\"amount\":null,\"amount_source\":0,\"currency\":\"USD\",\"round\":\"SPINOUT\",\"valuation\":null,\"valuation_generated_min\":null,\"valuation_generated_max\":null,\"news_source\":null,\"investors\":[{\"type\":\"university\",\"id\":936003,\"name\":\"Technical University Munich\",\"path\":\"technical_university_munich\",\"sub_types\":[],\"url\":\"https:\/\/app.dealroom.co\/universities\/technical_university_munich\",\"images\":{\"32x32\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/a8\/MzI6MzI6Y29tcGFueUBzMy1ldS13ZXN0LTEuYW1hem9uYXdzLmNvbS9kZWFscm9vbS1pbWFnZXMvMjAyNC8wMi8wOC85OGM2YjA2NzY5MDBmMDZhZGNjOTEzNDhmNTkwYTQ2MA==.png\",\"74x74\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/9d\/NzQ6NzQ6Y29tcGFueUBzMy1ldS13ZXN0LTEuYW1hem9uYXdzLmNvbS9kZWFscm9vbS1pbWFnZXMvMjAyNC8wMi8wOC85OGM2YjA2NzY5MDBmMDZhZGNjOTEzNDhmNTkwYTQ2MA==.png\",\"100x100\":\"https:\/\/storage.googleapis.com\/dealroom-images-production\/7f\/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzAyLzA4Lzk4YzZiMDY3NjkwMGYwNmFkY2M5MTM0OGY1OTBhNDYw.png\"},\"lead\":false}],\"is_verified\":true,\"amount_eur_million\":null,\"amount_usd_million\":null}],\"total\":6}}","_dealroom_json":"field_5ea15c251871a","dealroom_analytics_json":"{\"twitter_followers_chart\":[{\"date\":\"2021-07-19\",\"value\":1718},{\"date\":\"2021-09-29\",\"value\":301},{\"date\":\"2021-10-01\",\"value\":301},{\"date\":\"2021-11-02\",\"value\":301},{\"date\":\"2021-12-01\",\"value\":301},{\"date\":\"2022-01-23\",\"value\":302},{\"date\":\"2022-02-01\",\"value\":302},{\"date\":\"2022-03-04\",\"value\":304},{\"date\":\"2022-04-09\",\"value\":302},{\"date\":\"2022-05-24\",\"value\":300},{\"date\":\"2022-07-12\",\"value\":300},{\"date\":\"2022-08-09\",\"value\":298},{\"date\":\"2022-09-28\",\"value\":297},{\"date\":\"2022-10-08\",\"value\":297},{\"date\":\"2022-11-01\",\"value\":298},{\"date\":\"2023-02-19\",\"value\":286}],\"facebook_likes_chart\":[{\"date\":\"2023-02-28\",\"value\":353},{\"date\":\"2023-03-31\",\"value\":352},{\"date\":\"2023-04-30\",\"value\":352},{\"date\":\"2023-05-31\",\"value\":354},{\"date\":\"2023-08-31\",\"value\":356},{\"date\":\"2023-10-31\",\"value\":360},{\"date\":\"2023-11-30\",\"value\":360},{\"date\":\"2024-02-29\",\"value\":358},{\"date\":\"2024-03-31\",\"value\":359}]}","_dealroom_analytics_json":"field_5ea8354f2b0eb","_yoast_wpseo_focuskw":"Inveox","_yoast_wpseo_metadesc":"inveox entwickelt Systeme zur Digitalisierung und Automatisierung des Probeneingangs in der Histopathologie sowie zur Vernetzung von Pathologielaboren und behandelnden \u00c4rzten.","_yoast_wpseo_linkdex":"55","_yoast_wpseo_estimated-reading-time-minutes":"1","_wp_old_date":"2019-12-13","_wp_desired_post_slug":"","_year":"","_yoast_wpseo_wordproof_timestamp":"","_yoast_wpseo_focuskw_text_input":"","_original_post_id":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem\/79315"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/ecosystem"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=79315"}],"version-history":[{"count":1,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem\/79315\/revisions"}],"predecessor-version":[{"id":79318,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem\/79315\/revisions\/79318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/55838"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=79315"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=79315"},{"taxonomy":"ecosystem_type","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem_type?post=79315"},{"taxonomy":"ecosystem_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem_tag?post=79315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}